MCK Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$947.13median target· current $856.13 (+10.6%)17 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
9 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio22.32Forward 19.34
EPS (TTM)$38.3637.2% YoY
Profit margin1.2%HEALTHCARE
Market cap$101.33BLarge cap
Valuation
- Forward P/E
- 19.34
- PEG ratio
- 1.67
- P/B
- 5.04
- P/S (TTM)
- 0.26
- EV/EBITDA
- 14.61
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 2.2%
- Revenue growth YoY
- 6.0%
- Dividend yield
- 0.4%
- Beta
- 0.32
Last earnings
May 7, 2026 · Estimate $11.57 · Reported $11.69
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About McKesson Corporation
Company profileMcKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 6555 STATE HIGHWAY 161, IRVING, TX
- Fiscal year end
- March
- Latest quarter
- Mar 31, 2026
Market cap$101.33B
Shares outstanding$117.1M
52W high$997.90
52W low$634.42
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent